Sentences with phrase «neurological research on»
Neurological research on learning contributed to both the genesis and proliferation of the differentiation theory.
http://www.edudemic.com/ Not exact matches
Many pharmaceutical companies continue to work on treatments for neurological diseases, as do many smaller biotech firms and academic medical research centers, and funding sources for these pursuits include private foundations as well as governments.
Even with the addition of a video and keeping this story on the front page all weekend, she STILL makes the logical mistake of saying «here is what I have decided is the reality of the situation» (a reality which is HEAVILY debatable, especially in light of recent neurological research) and then went looking for whatever philosophy was the closest match for her preconceived determination of reality.
They've certainly not been focusing on the cutting - edge neurological and psychological research that Toronto - born journalist Paul Tough surveys in his remarkable — and remarkably hopeful — book How Children Succeed.
Neurological dynamics, and biological responses to trauma perception are on the forefront of much of the trauma research today.
Research has found that exposure to lead can have adverse neurological and cognitive effects on children.
And its Defense Sciences Office (DSO) has aligned with President Barack Obama's Brain Research through Advancing Innovative Neurotechnologies Initiative, calling for grant applications on projects to design therapeutic devices for neurological disorders and to repair brain damage in military service members.
To date, the only animal research on the neurological effects of space radiation has been done in rodents.
Lasmézas» research focuses on neurological disorders caused by misfolded proteins, such as Alzheimer's, Parkinson's, prion diseases, frontotemporal dementia and amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
Additional research funds were provided by the NIH Office of Dietary Supplements; the National Center for Complementary and Integrative Health; the National Institute on Aging; the National Heart, Lung, and Blood Institute; and the National Institute of Neurological Disorders and Stroke.
Research on lab animals has shown some of the chemicals cause cancerous tumors and damage developing brain cells, and some can alter hormones essential to reproductive and neurological development.
The research focus within the medical community has increasingly centered on the human intestine and its bacterial population, the so - called microbiome, especially in neurological disorders such as multiple sclerosis.
Pozzo - Miller reflects that this new research on LM22A - 4, combined with prior studies from the Katz lab, provides hope that at least some neurological and cognitive deficits in individuals with Rett could be improved by pharmacological treatment even after the onset of symptoms.
Other funding for the research was provided by grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute of Neurological Disorders and Stroke (NINDS).
«This bench to bedside research is very exciting and will have a major impact on the management of neurological diseases, particularly neuropathic pain,» said Akbar Panju, medical director of the Michael G. DeGroote Institute for Pain Research and Care, a clinician and professor of mresearch is very exciting and will have a major impact on the management of neurological diseases, particularly neuropathic pain,» said Akbar Panju, medical director of the Michael G. DeGroote Institute for Pain Research and Care, a clinician and professor of mResearch and Care, a clinician and professor of medicine.
Targeting conclusions that are closer to fiction than science, both Fine and Jordan - Young highlight exaggerations, unreplicated claims, and other silliness from research on neurological differences between the human sexes.
New research from University of Liverpool scientists has cast doubt on the theory that neurological behaviour is a product of culture in people of Chinese origin.
Specifically, the research team found that the experimental drug CX456, part of the AMPAkine class in clinical trials for several neurological conditions, counters for the dampening effect of anesthesia on nerve signaling.
Research by a Barrow Neurological Institute neurosurgery team on novel imaging technique assessment of patients with lumbar spine degeneration was published in the Aug. 28 issue of PLOS ONE.
So far, research has focused mainly on how signals from the gut can affect neurological functions, including some neurodegenerative diseases.
Dr. Palop's research focuses on understanding the neural processes underlying cognitive decline in Alzheimer's disease (AD) and in neurological conditions associated with destabilization of neuronal networks, such as epilepsy, autism, or schizophrenia.
The research was supported in part by four institutes of the National Institutes of Health — the National Institute on Drug Abuse, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, and the National Institute on Aging.
Neurological research at Gladstone focuses on a host of devastating conditions, including Alzheimer's, frontotemporal dementia (FTD), Parkinson's and Huntington's disease, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and multiple sclerosis.
Kessler Foundation Research Center focuses on improving function and quality of life for persons with injuries of the spinal cord and brain, stroke, multiple sclerosis, and other chronic neurological conditions.
His research is based on the concept that normal brain aging and the pathogeneses of sporadic neurological diseases are not a consequence of a few single or «disease - specific «factors alone, rather they are driven by holistic events that include one's individual genetic and epigenetic condition, progression of aging, and lifestyle.
The 19 NIH institutes, centers and offices contributing to the Knockout Mouse Project are: the NIH Office of Strategic Coordination / Common Fund; NCRR; the National Eye Institute; NHGRI; the National Institute of Allergy and Infectious Diseases; the National Heart, Lung and Blood Institute; the National Institute on Aging; the National Institute of Alcohol Abuse and Alcoholism; the National Institute of Arthritis and Musculoskeletal and Skin Diseases; the Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIDCD; the National Institute of Dental and Craniofacial Research; the National Institute of Environmental Health Sciences; the National Institute of General Medical Sciences; the National Institute of Mental Health; the National Institute of Neurological Disorders and Stroke; the National Institute of Diabetes and Digestive and Kidney Diseases; the National Cancer Institute; and the Office of AIDS Research.
The findings, published today in the online journal PloS One, open new opportunities for gaining a greater understanding of Alzheimer's disease and other neurological diseases and for developing therapies to halt its progression, according to senior author Karen E. Duff, PhD, professor of pathology (in psychiatry and in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain) at CUMC and at the New York State Psychiatric Institute.
The 19 NIH institutes, centers and offices contributing to the contracts are: National Center for Complementary and Alternative Medicine, National Center for Research Resources, National Eye Institute, National Human Genome Research Institute, National Heart, Lung and Blood Institute, National Institute on Aging, National Institute of Alcohol Abuse and Alcoholism, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Child Health and Human Development, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute on Drug Abuse, National Institute of Environmental Health Sciences, National Institute of General Medical Sciences, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Nursing Research, and the Office of AIDS Research.
Research focuses on improving function and quality of life for persons with injuries of the spinal cord and brain, stroke, multiple sclerosis, and other chronic neurological conditions.
Dr. Landis joined the National Institute of Neurological Disorders and Stroke in 1995 as Scientific Director and worked to re-engineer the lnstitute's intramural research program, and fostered the growth of a trans - NIH neuroscience community that led to the construction of the Porter Neuroscience Building on the NIH campus.
Funding was provided by the National Institute of Neurological Disorders and Stroke, Taube / Koret Center for Neurodegenerative Disease, Hellman Family Foundation Alzheimer's Disease Research Program, UCSF Medical Scientist Training Program, Hereditary Diseae Foundation, CHDI Foundation, and the National Institute on Aging.
Many of our neurologists are supported by grants from the National Institutes of Health for their basic research work on various neurological diseases, including Parkinson's disease, stroke, multiple sclerosis, ALS, and peripheral neuropathy.
He also held several positions of increasing leadership at Praecis Pharmaceuticals, including Director of Cell Biology, where he initiated or contributed to the establishment of numerous research projects focusing on the discovery of novel therapeutics for the treatment of cancer, inflammation, infectious disease, and neurological disorders.
So far, most research has focused on the neurological decline associated with schizophrenia — typically involving a loss of brain tissue.
Funding was provided by the National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse, National Institute of General Medical Sciences, National Center for Research Resources, Swiss National Science Foundations, and the State of California.
Sara Mole (UCL) discusses her work on Batten disease, as well as the universal challenges encountered when researching and treating rare neurological diseases.
Support for this research was provided by a Ruth L. Kirschstein Fellowship, the National Institute of Neurological Disease and Stroke, the National Institute on Aging and the Keck Foundation.
The National Institute of Neurological Disorders and Stroke is the nation's primary funder of research on the brain and nervous system.
«Our research on BBB disruption and the role certain proteins play in neuro - inflammation has advanced our efforts to explore unexpected culprits in neurological diseases,» Akassoglou said.
Gladstone Investigator Ken Nakamura, MD, PhD, and the National Institutes of Health Investigator Mark Cookson, PhD, also participated in this research, which was supported by the following: the de Clercq Family, the National Center for Research Resources (#RR189288), the Burroughs - Wellcome Medical Scientist Fund, the National Institute of Neurological Disorders and Stroke (#P30NS069496), the National Institute on Aging, the Taube - Koret Center for Huntington's Disease Research, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 Nresearch, which was supported by the following: the de Clercq Family, the National Center for Research Resources (#RR189288), the Burroughs - Wellcome Medical Scientist Fund, the National Institute of Neurological Disorders and Stroke (#P30NS069496), the National Institute on Aging, the Taube - Koret Center for Huntington's Disease Research, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 NResearch Resources (#RR189288), the Burroughs - Wellcome Medical Scientist Fund, the National Institute of Neurological Disorders and Stroke (#P30NS069496), the National Institute on Aging, the Taube - Koret Center for Huntington's Disease Research, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 NResearch, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 NS04549).
Building initially on world - leading pre-clinical and clinical research into epilepsy and motor neurone disease, the FutureNeuro Centre is a scalable platform that will expand quickly to focus on other chronic and rare neurological diseases.
«Gladstone is uniquely qualified to take on this major research, which will fill a critical gap in the understanding of brain function and neurological disease,» said Gladstone president Robert W. Mahley, MD, PhD.
It conducts, fosters, coordinates, and guides research on the causes, prevention, diagnosis, and treatment of neurological disorders and stroke, and supports basic research in related scientific areas.
Katerina Akassoglou's research on the brain's vascular and immune systems has led to new insights about multiple sclerosis and other neurological conditions.
«Because of this, the Core promotes interdisciplinary and translational research in behavioral neuroscience on a much broader scale, bringing researchers closer to better treatments for neurological and psychiatric diseases.»
«Our research on the role of blood proteins in brain functions has identified new targets for therapeutic intervention in multiple sclerosis and other neurological diseases,» said Dr. Akassoglou.
At the Gladstone Institutes, neuroscientists rely on the Behavioral Core to research brain functions in both healthy and disease states, investigating the causes of neurological disorders and creating new therapies to overcome them.
Funding was provided by the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, a National Institutes of Health Extramural Research Facilities Improvement Program Project, the Larry L. Hillblom Foundation, the Hellman Family Foundation, the Taube / Koret Center for Neurodegenerative Diseases, the American Federation for Aging Research, and the McKnight Endowment Fund for Neuroscience.
Funding was provided by the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the American Federation of Aging Research (AFAR), a MetLife / AFAR Award, and gifts from the S.D. Bechtel, Jr..
Phenome — Since the first publication on the BXDs, well over 200 research groups have generated behavioral, neurological, pharmacological, immunological, and more recently, metabolic phenotypes for this family.